APO RESEARCH · REPORT
Blood Bank (Blood Banking)
This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes refers to a collection center, and indeed some hospitals also perform collection.
Product & engineering
Understand the product.
This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes refers to a collection center, and indeed some hospitals also perform collection.
Selected research
Industry Research
Blood Bank (Blood Banking) Industry Research Report 2026
Market perspective
This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes refers to a collection center, and indeed some hospitals also perform collection.
North America is the largest consumption place, with a consumption market share more than 35%, It was followed by Europe with 25%. Shire (Baxalta), CSL and Grifols are the top 3 players of Blood Bank market, and they had a nearly 60% combined market share.
Report Scope
Read the full market overview
This report quantifies the global Blood Bank (Blood Banking) market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Blood Bank (Blood Banking).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood Bank (Blood Banking) Market by Company
American Red Cross
Japan Red Cross Society
New York Blood Center
Sanquin Blood Supply Foundation
America’s Blood Centers
Canadian Blood Services
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Sichuan Yuanda Shuyang
Abbott
Beckman Coulter
BD
Bio-Rad Laboratories
bioMérieux
Cerus
Haemonetics
Immucor
Fresenius Kabi
MacoPharma
Ortho-Clinical
Terumo BCT
Blood Bank (Blood Banking) Segment by Type
Whole Blood
Red Blood Cell
Platelet
Plasma
White Blood Cell
Blood Bank (Blood Banking) Segment by Application
Hospital
Clinic
Others
Blood Bank (Blood Banking) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Bank (Blood Banking) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Bank (Blood Banking) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Bank (Blood Banking).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Blood Bank (Blood Banking) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Blood
- Red Blood Cell
- Platelet
- Plasma
- White Blood Cell
Applications
- Hospital
- Clinic
- Others
Companies covered
- American Red Cross
- Japan Red Cross Society
- New York Blood Center
- Sanquin Blood Supply Foundation
- America’s Blood Centers
- Canadian Blood Services
- Shire (Baxalta)
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Sichuan Yuanda Shuyang
- Abbott
- Beckman Coulter
- BD
- Bio-Rad Laboratories
- bioMérieux
- Cerus
- Haemonetics
- Immucor
- Fresenius Kabi
- MacoPharma
- Ortho-Clinical
- Terumo BCT
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Blood Bank (Blood Banking) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Whole Blood
- 2.2.3 Red Blood Cell
- 2.2.4 Platelet
- 2.2.5 Plasma
- 2.2.6 White Blood Cell
- 2.3 Blood Bank (Blood Banking) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Blood Bank (Blood Banking) Breakdown Data by Type
- 3.1 Global Blood Bank (Blood Banking) Historic Market Size by Type (2021-2026)
- 3.2 Global Blood Bank (Blood Banking) Forecasted Market Size by Type (2027-2032)
4 Blood Bank (Blood Banking) Breakdown Data by Application
- 4.1 Global Blood Bank (Blood Banking) Historic Market Size by Application (2021-2026)
- 4.2 Global Blood Bank (Blood Banking) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Blood Bank (Blood Banking) Market Perspective (2021-2032)
- 5.2 Global Blood Bank (Blood Banking) Growth Trends by Region
- 5.2.1 Global Blood Bank (Blood Banking) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Blood Bank (Blood Banking) Historic Market Size by Region (2021-2026)
- 5.2.3 Blood Bank (Blood Banking) Forecasted Market Size by Region (2027-2032)
- 5.3 Blood Bank (Blood Banking) Market Dynamics
- 5.3.1 Blood Bank (Blood Banking) Industry Trends
- 5.3.2 Blood Bank (Blood Banking) Market Drivers
- 5.3.3 Blood Bank (Blood Banking) Market Challenges
- 5.3.4 Blood Bank (Blood Banking) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Blood Bank (Blood Banking) Players by Revenue
- 6.1.1 Global Top Blood Bank (Blood Banking) Players by Revenue (2021-2026)
- 6.1.2 Global Blood Bank (Blood Banking) Revenue Market Share by Players (2021-2026)
- 6.2 Global Blood Bank (Blood Banking) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Blood Bank (Blood Banking) Head Office and Area Served
- 6.4 Global Blood Bank (Blood Banking) Players, Product Type & Application
- 6.5 Global Blood Bank (Blood Banking) Manufacturers Established Date
- 6.6 Global Blood Bank (Blood Banking) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Blood Bank (Blood Banking) Market Size (2021-2032)
- 7.2 North America Blood Bank (Blood Banking) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Blood Bank (Blood Banking) Market Size by Country (2021-2026)
- 7.4 North America Blood Bank (Blood Banking) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Blood Bank (Blood Banking) Market Size (2021-2032)
- 8.2 Europe Blood Bank (Blood Banking) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Blood Bank (Blood Banking) Market Size by Country (2021-2026)
- 8.4 Europe Blood Bank (Blood Banking) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Blood Bank (Blood Banking) Market Size (2021-2032)
- 9.2 Asia-Pacific Blood Bank (Blood Banking) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Blood Bank (Blood Banking) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Blood Bank (Blood Banking) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Blood Bank (Blood Banking) Market Size (2021-2032)
- 10.2 South America Blood Bank (Blood Banking) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Blood Bank (Blood Banking) Market Size by Country (2021-2026)
- 10.4 South America Blood Bank (Blood Banking) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Blood Bank (Blood Banking) Market Size (2021-2032)
- 11.2 Middle East & Africa Blood Bank (Blood Banking) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Blood Bank (Blood Banking) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Blood Bank (Blood Banking) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 American Red Cross
- 12.1.1 American Red Cross Company Information
- 12.1.2 American Red Cross Business Overview
- 12.1.3 American Red Cross Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.1.4 American Red Cross Blood Bank (Blood Banking) Product Portfolio
- 12.1.5 American Red Cross Recent Developments
- 12.2 Japan Red Cross Society
- 12.2.1 Japan Red Cross Society Company Information
- 12.2.2 Japan Red Cross Society Business Overview
- 12.2.3 Japan Red Cross Society Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.2.4 Japan Red Cross Society Blood Bank (Blood Banking) Product Portfolio
- 12.2.5 Japan Red Cross Society Recent Developments
- 12.3 New York Blood Center
- 12.3.1 New York Blood Center Company Information
- 12.3.2 New York Blood Center Business Overview
- 12.3.3 New York Blood Center Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.3.4 New York Blood Center Blood Bank (Blood Banking) Product Portfolio
- 12.3.5 New York Blood Center Recent Developments
- 12.4 Sanquin Blood Supply Foundation
- 12.4.1 Sanquin Blood Supply Foundation Company Information
- 12.4.2 Sanquin Blood Supply Foundation Business Overview
- 12.4.3 Sanquin Blood Supply Foundation Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.4.4 Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Product Portfolio
- 12.4.5 Sanquin Blood Supply Foundation Recent Developments
- 12.5 America’s Blood Centers
- 12.5.1 America’s Blood Centers Company Information
- 12.5.2 America’s Blood Centers Business Overview
- 12.5.3 America’s Blood Centers Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.5.4 America’s Blood Centers Blood Bank (Blood Banking) Product Portfolio
- 12.5.5 America’s Blood Centers Recent Developments
- 12.6 Canadian Blood Services
- 12.6.1 Canadian Blood Services Company Information
- 12.6.2 Canadian Blood Services Business Overview
- 12.6.3 Canadian Blood Services Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.6.4 Canadian Blood Services Blood Bank (Blood Banking) Product Portfolio
- 12.6.5 Canadian Blood Services Recent Developments
- 12.7 Shire (Baxalta)
- 12.7.1 Shire (Baxalta) Company Information
- 12.7.2 Shire (Baxalta) Business Overview
- 12.7.3 Shire (Baxalta) Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.7.4 Shire (Baxalta) Blood Bank (Blood Banking) Product Portfolio
- 12.7.5 Shire (Baxalta) Recent Developments
- 12.8 CSL
- 12.8.1 CSL Company Information
- 12.8.2 CSL Business Overview
- 12.8.3 CSL Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.8.4 CSL Blood Bank (Blood Banking) Product Portfolio
- 12.8.5 CSL Recent Developments
- 12.9 Grifols
- 12.9.1 Grifols Company Information
- 12.9.2 Grifols Business Overview
- 12.9.3 Grifols Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.9.4 Grifols Blood Bank (Blood Banking) Product Portfolio
- 12.9.5 Grifols Recent Developments
- 12.10 Octapharma
- 12.10.1 Octapharma Company Information
- 12.10.2 Octapharma Business Overview
- 12.10.3 Octapharma Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.10.4 Octapharma Blood Bank (Blood Banking) Product Portfolio
- 12.10.5 Octapharma Recent Developments
- 12.11 Kedrion
- 12.11.1 Kedrion Company Information
- 12.11.2 Kedrion Business Overview
- 12.11.3 Kedrion Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.11.4 Kedrion Blood Bank (Blood Banking) Product Portfolio
- 12.11.5 Kedrion Recent Developments
- 12.12 LFB Group
- 12.12.1 LFB Group Company Information
- 12.12.2 LFB Group Business Overview
- 12.12.3 LFB Group Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.12.4 LFB Group Blood Bank (Blood Banking) Product Portfolio
- 12.12.5 LFB Group Recent Developments
- 12.13 Biotest
- 12.13.1 Biotest Company Information
- 12.13.2 Biotest Business Overview
- 12.13.3 Biotest Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.13.4 Biotest Blood Bank (Blood Banking) Product Portfolio
- 12.13.5 Biotest Recent Developments
- 12.14 BPL
- 12.14.1 BPL Company Information
- 12.14.2 BPL Business Overview
- 12.14.3 BPL Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.14.4 BPL Blood Bank (Blood Banking) Product Portfolio
- 12.14.5 BPL Recent Developments
- 12.15 RAAS
- 12.15.1 RAAS Company Information
- 12.15.2 RAAS Business Overview
- 12.15.3 RAAS Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.15.4 RAAS Blood Bank (Blood Banking) Product Portfolio
- 12.15.5 RAAS Recent Developments
- 12.16 CBPO
- 12.16.1 CBPO Company Information
- 12.16.2 CBPO Business Overview
- 12.16.3 CBPO Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.16.4 CBPO Blood Bank (Blood Banking) Product Portfolio
- 12.16.5 CBPO Recent Developments
- 12.17 Hualan Bio
- 12.17.1 Hualan Bio Company Information
- 12.17.2 Hualan Bio Business Overview
- 12.17.3 Hualan Bio Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.17.4 Hualan Bio Blood Bank (Blood Banking) Product Portfolio
- 12.17.5 Hualan Bio Recent Developments
- 12.18 Sichuan Yuanda Shuyang
- 12.18.1 Sichuan Yuanda Shuyang Company Information
- 12.18.2 Sichuan Yuanda Shuyang Business Overview
- 12.18.3 Sichuan Yuanda Shuyang Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.18.4 Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Product Portfolio
- 12.18.5 Sichuan Yuanda Shuyang Recent Developments
- 12.19 Abbott
- 12.19.1 Abbott Company Information
- 12.19.2 Abbott Business Overview
- 12.19.3 Abbott Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.19.4 Abbott Blood Bank (Blood Banking) Product Portfolio
- 12.19.5 Abbott Recent Developments
- 12.20 Beckman Coulter
- 12.20.1 Beckman Coulter Company Information
- 12.20.2 Beckman Coulter Business Overview
- 12.20.3 Beckman Coulter Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.20.4 Beckman Coulter Blood Bank (Blood Banking) Product Portfolio
- 12.20.5 Beckman Coulter Recent Developments
- 12.21 BD
- 12.21.1 BD Company Information
- 12.21.2 BD Business Overview
- 12.21.3 BD Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.21.4 BD Blood Bank (Blood Banking) Product Portfolio
- 12.21.5 BD Recent Developments
- 12.22 Bio-Rad Laboratories
- 12.22.1 Bio-Rad Laboratories Company Information
- 12.22.2 Bio-Rad Laboratories Business Overview
- 12.22.3 Bio-Rad Laboratories Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.22.4 Bio-Rad Laboratories Blood Bank (Blood Banking) Product Portfolio
- 12.22.5 Bio-Rad Laboratories Recent Developments
- 12.23 bioMérieux
- 12.23.1 bioMérieux Company Information
- 12.23.2 bioMérieux Business Overview
- 12.23.3 bioMérieux Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.23.4 bioMérieux Blood Bank (Blood Banking) Product Portfolio
- 12.23.5 bioMérieux Recent Developments
- 12.24 Cerus
- 12.24.1 Cerus Company Information
- 12.24.2 Cerus Business Overview
- 12.24.3 Cerus Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.24.4 Cerus Blood Bank (Blood Banking) Product Portfolio
- 12.24.5 Cerus Recent Developments
- 12.25 Haemonetics
- 12.25.1 Haemonetics Company Information
- 12.25.2 Haemonetics Business Overview
- 12.25.3 Haemonetics Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.25.4 Haemonetics Blood Bank (Blood Banking) Product Portfolio
- 12.25.5 Haemonetics Recent Developments
- 12.26 Immucor
- 12.26.1 Immucor Company Information
- 12.26.2 Immucor Business Overview
- 12.26.3 Immucor Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.26.4 Immucor Blood Bank (Blood Banking) Product Portfolio
- 12.26.5 Immucor Recent Developments
- 12.27 Fresenius Kabi
- 12.27.1 Fresenius Kabi Company Information
- 12.27.2 Fresenius Kabi Business Overview
- 12.27.3 Fresenius Kabi Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.27.4 Fresenius Kabi Blood Bank (Blood Banking) Product Portfolio
- 12.27.5 Fresenius Kabi Recent Developments
- 12.28 MacoPharma
- 12.28.1 MacoPharma Company Information
- 12.28.2 MacoPharma Business Overview
- 12.28.3 MacoPharma Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.28.4 MacoPharma Blood Bank (Blood Banking) Product Portfolio
- 12.28.5 MacoPharma Recent Developments
- 12.29 Ortho-Clinical
- 12.29.1 Ortho-Clinical Company Information
- 12.29.2 Ortho-Clinical Business Overview
- 12.29.3 Ortho-Clinical Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.29.4 Ortho-Clinical Blood Bank (Blood Banking) Product Portfolio
- 12.29.5 Ortho-Clinical Recent Developments
- 12.30 Terumo BCT
- 12.30.1 Terumo BCT Company Information
- 12.30.2 Terumo BCT Business Overview
- 12.30.3 Terumo BCT Revenue in Blood Bank (Blood Banking) Business (2021-2026)
- 12.30.4 Terumo BCT Blood Bank (Blood Banking) Product Portfolio
- 12.30.5 Terumo BCT Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst